Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04215783

Childhood Allergy and the Neonatal Environment

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
499 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to study the relationship between childhood asthma, allergies, and early-life environmental factors that may cause childhood asthma and allergies. Previous birth cohort studies have found early-life environmental factors such as allergies, pollutants, viruses and bacteria have all contributed to the development of asthma and allergies. Investigators are doing this research because there continues to be a strong need to understand the root causes of asthma and allergies. The CANOE study is an observational cohort study, which means investigators are not asking participants or participant's child to change their medications and investigators will not be giving participants or participant's child a study drug.

Detailed description

The CANOE study will provide an opportunity to collect novel longitudinal samples not available from the current CANOE birth cohorts, as well as enhanced and standardized environmental sampling in early life. One of the main goals of this study is to gather data and specimens, beginning in the prenatal periods, that will assess environmental exposures to toxins and microbes, and host characteristics including genetics, epigenetics, gene expression, the proteome and metabolome, microbial colonization and viral respiratory infections. The main study outcomes will be important interim conditions (e.g., recurrent wheeze, early multiple sensitization) that are highly associated with the development of asthma. Additional outcomes (perinatal outcomes, growth, neurocognitive development) will be collected as part of the collaborative Environmental Influences on Child Health Outcomes (ECHO)-wide Cohort Data Collection Protocol.

Conditions

Timeline

Start date
2020-03-04
Primary completion
2027-08-31
Completion
2027-08-31
First posted
2020-01-02
Last updated
2026-02-10

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04215783. Inclusion in this directory is not an endorsement.